Birdwatch Note Rating
2024-11-29 03:02:31 UTC - NOT_HELPFUL
Rated by Participant: AA554F50761B45FB7D417E104BA17F4004B1274F0259C3B12B8F8465B7E08CA7
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details